BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35720727)

  • 1. Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease.
    Brinkley TE; Leng I; Register TC; Neth BJ; Zetterberg H; Blennow K; Craft S
    Front Neurosci; 2022; 16():906539. PubMed ID: 35720727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
    Neth BJ; Mintz A; Whitlow C; Jung Y; Solingapuram Sai K; Register TC; Kellar D; Lockhart SN; Hoscheidt S; Maldjian J; Heslegrave AJ; Blennow K; Cunnane SC; Castellano CA; Zetterberg H; Craft S
    Neurobiol Aging; 2020 Feb; 86():54-63. PubMed ID: 31757576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.
    Moreno B; Crujeiras AB; Bellido D; Sajoux I; Casanueva FF
    Endocrine; 2016 Dec; 54(3):681-690. PubMed ID: 27623967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment.
    Kumar A; Sharma M; Su Y; Singh S; Hsu FC; Neth BJ; Register TC; Blennow K; Zetterberg H; Craft S; Deep G
    Brain Commun; 2022; 4(6):fcac262. PubMed ID: 36337342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.
    Phillips MCL; Deprez LM; Mortimer GMN; Murtagh DKJ; McCoy S; Mylchreest R; Gilbertson LJ; Clark KM; Simpson PV; McManus EJ; Oh JE; Yadavaraj S; King VM; Pillai A; Romero-Ferrando B; Brinkhuis M; Copeland BM; Samad S; Liao S; Schepel JAC
    Alzheimers Res Ther; 2021 Feb; 13(1):51. PubMed ID: 33622392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ad libitum Mediterranean diet reduces subcutaneous but not visceral fat in patients with coronary heart disease: A randomised controlled pilot study.
    Mayr HL; Itsiopoulos C; Tierney AC; Kucianski T; Radcliffe J; Garg M; Willcox J; Thomas CJ
    Clin Nutr ESPEN; 2019 Aug; 32():61-69. PubMed ID: 31221292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.
    Heianza Y; Ma W; Huang T; Wang T; Zheng Y; Smith SR; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2016 Nov; 39(11):1909-1914. PubMed ID: 27581055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of ultra-processed foods in visceral fat deposition and other adiposity indicators: Prospective analysis nested in the PREDIMED-Plus trial.
    Konieczna J; Morey M; Abete I; Bes-Rastrollo M; Ruiz-Canela M; Vioque J; Gonzalez-Palacios S; Daimiel L; Salas-Salvadó J; Fiol M; Martín V; Estruch R; Vidal J; Martínez-González MA; Canudas S; Jover AJ; Fernández-Villa T; Casas R; Olbeyra R; Buil-Cosiales P; Babio N; Schröder H; Martínez JA; Romaguera D;
    Clin Nutr; 2021 Jun; 40(6):4290-4300. PubMed ID: 33610419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
    Grau-Rivera O; Navalpotro-Gomez I; Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Arenaza-Urquijo EM; Salvadó G; Sala-Vila A; Shekari M; González-de-Echávarri JM; Minguillón C; Niñerola-Baizán A; Perissinotti A; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL;
    Alzheimers Res Ther; 2021 Feb; 13(1):46. PubMed ID: 33597012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment.
    Russin KJ; Nair KS; Montine TJ; Baker LD; Craft S
    J Alzheimers Dis; 2021; 84(2):843-853. PubMed ID: 34602470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    medRxiv; 2023 Nov; ():. PubMed ID: 38076824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant starch lowers postprandial glucose and leptin in overweight adults consuming a moderate-to-high-fat diet: a randomized-controlled trial.
    Maziarz MP; Preisendanz S; Juma S; Imrhan V; Prasad C; Vijayagopal P
    Nutr J; 2017 Feb; 16(1):14. PubMed ID: 28222742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ketogenic diet on body composition during resistance training in trained men: a randomized controlled trial.
    Vargas S; Romance R; Petro JL; Bonilla DA; Galancho I; Espinar S; Kreider RB; Benítez-Porres J
    J Int Soc Sports Nutr; 2018 Jul; 15(1):31. PubMed ID: 29986720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment.
    Baker LD; Bayer-Carter JL; Skinner J; Montine TJ; Cholerton BA; Callaghan M; Leverenz JB; Walter BK; Tsai E; Postupna N; Lampe J; Craft S
    J Alzheimers Dis; 2012; 28(1):137-46. PubMed ID: 21971406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men.
    Hall KD; Chen KY; Guo J; Lam YY; Leibel RL; Mayer LE; Reitman ML; Rosenbaum M; Smith SR; Walsh BT; Ravussin E
    Am J Clin Nutr; 2016 Aug; 104(2):324-33. PubMed ID: 27385608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.
    Neeland IJ; Turer AT; Ayers CR; Powell-Wiley TM; Vega GL; Farzaneh-Far R; Grundy SM; Khera A; McGuire DK; de Lemos JA
    JAMA; 2012 Sep; 308(11):1150-9. PubMed ID: 22990274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
    Heianza Y; Sun D; Smith SR; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2018 Mar; 41(3):413-419. PubMed ID: 29305401
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.